|
Variable
|
Case group (n = 43)
|
Control group (n = 42)
|
P valuea
|
|---|
|
hs-CRP (g/mlµ)
|
4.68 ± 4.36
|
2.92 ± 4.55
|
0.011
|
|
TAC(mmol/L)
|
2.46 ± 0.49
|
2.83 ± 0.82
|
0.065
|
|
MDA (nmol/ml)
|
2.63 ± 0.71
|
1.98 ± 0.90
|
> 0.001
|
|
SOD (U/ml)
|
78.89 ± 37.93
|
154.25 ± 115.93
|
> 0.001
|
|
PLA2 (pg/ml)
|
6.81 ± 2.22
|
4.73 ± 2.97
|
> 0.001
|
|
PF
|
68.67 ± 2.631
|
75.89 ± 18.95
|
0.057
|
|
RP
|
34.44 ± 42.40
|
60.00 ± 42.44
|
0.004
|
|
RE
|
37.02 ± 41.57
|
59.98 ± 41.19
|
0.010
|
|
EF
|
55.50 ± 18.82
|
62.88 ± 20.35
|
0.077
|
|
EW
|
61.51 ± 16.87
|
67.75 ± 17.42
|
0.073
|
|
SF
|
62.55 ± 24.57
|
72.50 ± 24.65
|
0.033
|
|
P
|
48.5 ± 20.91
|
79.27 ± 28.38
|
0.028
|
|
GH
|
51.81 ± 20.91
|
63.13 ± 20.64
|
0.011
|
|
PH
|
202.97 ± 85.09
|
278.30 ± 88.36
|
0.001
|
|
MH
|
213.44 ± 79.18
|
264.61 ± 65.87
|
0.001
|
- Values are means ± SD
- CRP C-reactive protein, EF energy/fatigue, EW emotional wellbeing, GH general health, hs-CRP high-sensitive, MDA malondialdehyde, MH mental health, P pain, PF physical function, PH physical health, PLA phospholipase A2, RE role limitation due to emotional problems, RP role limitation due to physical health, SF social function, SOD superoxide dismutase, TAC total antioxidant capacity
- aSignificantly different at p < 0.05 by Independent-Samples T test, Mann–Whitney U test or chi-square test
